Search Results

There are 3100 results for: content related to: Current antiviral therapies for chronic hepatitis B

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Absence of a Pharmacokinetic Interaction Between Entecavir and Adefovir

    The Journal of Clinical Pharmacology

    Volume 47, Issue 10, October 2007, Pages: 1327–1334, Mr Marc Bifano, Dr Jing-He Yan, Dr Robert A. Smith, Dr Duxi Zhang, Dr Dennis M. Grasela and Dr Frank LaCreta

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007304780

  3. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  4. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  5. Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 26–33, Guan Huei Lee, Myat Oo Aung, Yock Young Dan, Yin Mei Lee, Belinda Mak, How Cheng Low, Kieron Lim, Maung Aye Thwin, Poh Seng Tan and Seng Gee Lim

    Version of Record online : 28 SEP 2012, DOI: 10.1002/jmv.23392

  6. Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy

    Journal of Viral Hepatitis

    Volume 21, Issue 8, August 2014, Pages: e55–e64, Chien-Hung Chen, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu and Chuan-Mo Lee

    Version of Record online : 28 APR 2014, DOI: 10.1111/jvh.12239

  7. You have free access to this content
    Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 8, October 2011, Pages: 972–981, A. Ong, V. W.-S. Wong, G. L.-H. Wong, H.-Y. Chan, C.-H. Tse and H. L.-Y. Chan

    Version of Record online : 24 AUG 2011, DOI: 10.1111/j.1365-2036.2011.04833.x

  8. Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial

    Liver International

    Volume 33, Issue 2, February 2013, Pages: 244–254, Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Chang Wook Kim, Chang Don Lee, Sang Hoon Park, Myung Seok Lee, Choong Kee Park, Hee Bok Chae, Moon Young Kim, Soon Koo Baik, Yun Soo Kim, Ju Hyun Kim, Jung Il Lee, Jin Woo Lee, Sun Pyo Hong and Soon Ho Um

    Version of Record online : 7 JAN 2013, DOI: 10.1111/liv.12036

  9. You have free access to this content
    Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 137–150, Geoffrey Dusheiko

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12078

  10. You have free access to this content
    Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 7, April 2013, Pages: 710–719, J. L. Hartono, M. O. Aung, Y. Y. Dan, M. Gowans, K. Lim, Y. M. Lee, G. H. Lee, H. C. Low, P. S. Tan, M. A. Thwin, C. Soon, L.-L. Chiu, M. J. Khoo, E. Koay and S. G. Lim

    Version of Record online : 21 FEB 2013, DOI: 10.1111/apt.12251

  11. You have free access to this content
    Poster Session 4: Hepatitis B Therapy

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1088A–1128A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27532

  12. You have free access to this content
    Evolution of multi-drug resistant hepatitis B virus during sequential therapy

    Hepatology

    Volume 44, Issue 3, September 2006, Pages: 703–712, Hyung Joon Yim, Munira Hussain, Ying Liu, Stephen N. Wong, Scott K. Fung and Anna S. F. Lok

    Version of Record online : 29 AUG 2006, DOI: 10.1002/hep.21290

  13. Treatment of chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 333–345, P. Marcellin, T. Asselah and N. Boyer

    Version of Record online : 28 JUN 2005, DOI: 10.1111/j.1365-2893.2005.00599.x

  14. You have free access to this content
    Complex dynamics of hepatitis B virus resistance to adefovir

    Hepatology

    Volume 49, Issue 1, January 2009, Pages: 50–59, Coralie Pallier, Christophe Rodriguez, Rozenn Brillet, Patrice Nordmann, Christophe Hézode and Jean-Michel Pawlotsky

    Version of Record online : 18 SEP 2008, DOI: 10.1002/hep.22634

  15. You have free access to this content
    Management of hepatitis B: Summary of a clinical research workshop

    Hepatology

    Volume 45, Issue 4, April 2007, Pages: 1056–1075, Jay H. Hoofnagle, Edward Doo, T. Jake Liang, Russell Fleischer and Anna S.F. Lok

    Version of Record online : 28 MAR 2007, DOI: 10.1002/hep.21627

  16. Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains

    Journal of Viral Hepatitis

    Volume 20, Issue 2, February 2013, Pages: 141–148, U. Herbers, S. Amini-Bavil-Olyaee, A. Mueller, T. Luedde, C. Trautwein and F. Tacke

    Version of Record online : 3 JUL 2012, DOI: 10.1111/j.1365-2893.2012.01639.x

  17. You have free access to this content
    Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 12, June 2008, Pages: 1240–1252, D. L. VEENSTRA, D. E. SPACKMAN, A. BISCEGLIE, K. V. KOWDLEY and R. G. GISH

    Version of Record online : 27 MAR 2008, DOI: 10.1111/j.1365-2036.2008.03691.x

    Corrected by:

    Erratum

    Vol. 28, Issue 1, 166, Version of Record online: 2 JUN 2008

  18. You have free access to this content
    Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis

    Value in Health

    Volume 13, Issue 5, August 2010, Pages: 592–600, Bin Wu, Te Li, Huafeng Chen and Jinfang Shen

    Version of Record online : 30 APR 2010, DOI: 10.1111/j.1524-4733.2010.00733.x

  19. Characteristics of adefovir resistance in patients with or without lamivudine-resistant hepatitis B virus treated with adefovir: a 4-year experience

    Liver International

    Volume 31, Issue 2, February 2011, Pages: 206–214, Chien-Hung Chen, Jing-Houng Wang, Sheng-Nan Lu, Tsung-Hui Hu, Chao-Hung Hung, Min-Hui Chang, Chi-Sin Changchien and Chuan-Mo Lee

    Version of Record online : 8 DEC 2010, DOI: 10.1111/j.1478-3231.2010.02416.x

  20. Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B

    Clinical Transplantation

    Volume 24, Issue 2, March/April 2010, Pages: 207–212, Kai Chung Tse, Desmond Y. H. Yap, Colin S. O. Tang, Susan Yung and Tak Mao Chan

    Version of Record online : 16 SEP 2009, DOI: 10.1111/j.1399-0012.2009.01090.x